Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3052008 | 0.86 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL18306112 | 0.82 | ALDH1A1 (0.42) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL4960492 | 0.82 | ALDH1A1 (0.42) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL30729473 | 0.82 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL8668862 | 0.82 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL28789360 | 0.81 | KCNH2 (0.38) | ALDH1A1CYP1A2CYP2C19CYP2D6TSHR | |
| SCHEMBL611879 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL21750002 | 0.81 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL8063523 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP1A2CYP2C19CYP2D6CDK2 | |
| SCHEMBL28252852 | 0.81 | ALB (0.47) | ALDH1A1CDK2TSHRSMN1; SMN2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313954-B1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD (IL) | 2025-10-15 | — | — | EP | claimed |
| US-20240217915-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2024-07-04 | — | — | US | claimed |
| EP-4313954-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | Adama Agan Ltd. (IL) | 2024-02-07 | — | — | EP | claimed |
| CN-117062805-A | Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid | 安道麦阿甘有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20260085051-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2026-03-26 | — | — | US | disclosed |
| EP-4313954-B1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD (IL) | 2025-10-15 | — | — | EP | disclosed |
| CN-119790033-A | Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid | 安道麦阿甘有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240217915-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2024-07-04 | — | — | US | disclosed |
| US-20240217915-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2024-07-04 | — | — | US | disclosed |
| WO-2024047648-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2024-03-07 | — | — | WO | disclosed |
| EP-4313954-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | Adama Agan Ltd. (IL) | 2024-02-07 | — | — | EP | disclosed |
| EP-4313954-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | Adama Agan Ltd. (IL) | 2024-02-07 | — | — | EP | disclosed |
| WO-2018141642-A1 | PROCESS FOR THE PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOTRICHLORIDE | BASF Agro B.V. (NL) | 2018-08-09 | — | — | WO | disclosed |
| US-20120310010-A1 | Method for producing sulfonamides | BASF SE (DE) | 2012-12-06 | — | — | US | disclosed |
| CN-101351443-B | Process for preparing sulfonamides | BASF SE | 2012-11-28 | — | — | CN | disclosed |
| US-8263806-B2 | Method for producing sulfonamides | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-20100228054-A1 | Method for Producing Sulfonamides | BASF SE (DE) | 2010-09-09 | — | — | US | disclosed |
| CN-101351443-A | Process for preparing sulfonamides | BASF AG (DE) | 2009-01-21 | — | — | CN | disclosed |
| EP-1957443-A2 | METHOD FOR PRODUCING SULFONAMIDES | BASF SE (DE) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007063028-A2 | METHOD FOR PRODUCING SULFONAMIDES | BASF SE (DE) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100228054-A1 | Method for Producing Sulfonamides | STS, MSRB3, SQOR | ALDH1A1 1345/4885CYP1A2 207/4885CYP2C19 276/4885 |
| US-20120310010-A1 | Method for producing sulfonamides | MSRB3, STS, TST | ALDH1A1 2610/4885CYP1A2 590/4885CYP2C19 540/4885 |
| US-20240217915-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | CYP4F12, COXFA4, NDUFS5 | ALDH1A1 500/4885CYP1A2 251/4885CYP2C19 421/4885 |
| US-20260085051-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | FOSB, DDT, NPM1 | ALDH1A1 1129/4885CYP1A2 320/4885CYP2C19 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.